A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety, efficacy and tolerability of R940343 in the treatment of mild to moderate asthma.

Phase 2

Rigel Pharmaceuticals